Author

M. I. Nishimura

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Ulijasz· 1 shared A. Vuchkovska· 1 shared C. M. Paulos· 1 shared D. Glanville· 1 shared G. Scurti· 1 shared H. E. Broxmeyer· 1 shared H. M. Knochelmann· 1 shared J. S. Bowers· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Ulijasz

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Siglec-5 is an inhibitory immune checkpoint molecule for human T cells

A. Vuchkovska, D. Glanville, G. Scurti, P. White, M. I. Nishimura, A. Ulijasz, M. J. Iwashima

This study identifies Siglec-5 as an inhibitory checkpoint molecule on activated human T cells that suppresses TCR-mediated activation and effector functions.

bioRxiv · Jan 4, 2022Immunology

Identification of human CD4+ T cell populations with distinct antitumor activity

M. H. Nelson, H. M. Knochelmann, S. R. Bailey, L. W. Huff, J. S. Bowers, K. Majchrzak, M. M. Wyatt, M. P. Rubinstein, S. Mehrotra, M. I. Nishimura, K. Armeson, P. G. Giresi, M. J. Zilliox, H. E. Broxmeyer, C. M. Paulos

The paper identifies human CD4+ T cell populations with distinct antitumor activity, showing CD26high T cells are epigenetically and transcriptionally different from Th17 cells and are more effective in tumor therapy.

bioRxiv · Dec 31, 2019Immunology